Comparative Analysis of the Multiple Test Methods for the Detection of Pandemic Influenza A/H1N1 2009 Virus

2010 ◽  
Vol 20 (10) ◽  
pp. 1450-1456 ◽  
Author(s):  
Young Jin Choi
Keyword(s):  
Comparative Analysis ◽  
Pandemic Influenza ◽  
Influenza A ◽  
Test Methods ◽  
Multiple Test ◽  
Influenza A H1n1

Morbimortality of Pandemic Influenza A H1N1 Infection in Kidney Transplant Recipients Requiring Hospitalization: A Comparative Analysis With Nonimmunocompromised Patients

2012 ◽  
Vol 93 (1) ◽  
pp. 69-72 ◽  
Author(s):  
Luis Fernando A. Camargo ◽  
Tainá V. de Sandes-Freitas ◽  
Camila D. R. Silva ◽  
Carolina D. Bittante ◽  
Gislaine Ono ◽  
...  
Keyword(s):  
Comparative Analysis ◽  
Kidney Transplant ◽  
Pandemic Influenza ◽  
Influenza A ◽  
H1n1 Infection ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Influenza A H1n1

scholarly journals Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak

2009 ◽  
Vol 45 (3) ◽  
pp. 191-195 ◽  
Author(s):  
Christine C. Ginocchio ◽  
Frank Zhang ◽  
Ryhana Manji ◽  
Suman Arora ◽  
Mark Bornfreund ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
York City ◽  
Influenza A ◽  
Test Methods ◽  
The Novel ◽  
Multiple Test ◽  
Influenza A H1n1

scholarly journals Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19

2021 ◽  
Author(s):  
José Alberto Choreño-Parra ◽  
Luis Armando Jiménez-Álvarez ◽  
Gustavo Ramírez-Martínez ◽  
Alfredo Cruz-Lagunas ◽  
Mahima Thapa ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Alveolar Epithelium ◽  
Surfactant Protein ◽  
High Serum ◽  
Surfactant Protein D ◽  
Diagnostic Challenge ◽  
Moderate Disease ◽  
Influenza A H1n1 ◽  
Novel Biomarkers

Abstract The differentiation of influenza and COVID-19 could constitute a diagnostic challenge during the ongoing winter due to their clinical similitude. Thus, novel biomarkers that enable distinguishing both diseases are required. Here, we evaluated whether the surfactant protein D (SP-D), a collectin produced at the alveolar epithelium with known immune properties, was useful to differentiate pandemic influenza A(H1N1) from COVID-19 in critically ill patients. Our results revealed high serum SP-D levels in severe pandemic influenza but not COVID-19 patients. This finding was validated in a separate cohort of mechanically ventilated COVID-19 patients who also showed low plasma SP-D levels. However, plasma SP-D levels did not distinguish seasonal influenza from COVID-19 in mild-to-moderate disease. Finally, we found that high serum SP-D levels were associated with mortality and renal failure among severe pandemic influenza cases. Thus, our studies have identified SP-D as a unique biomarker expressed during severe pandemic influenza but not COVID-19.

scholarly journals Ultrastructural and Histopathological Studies of 2009 Pandemic Influenza A (H1N1) Virus

2010 ◽  
Vol 16 (S2) ◽  
pp. 1122-1123
Author(s):  
CS Goldsmith ◽  
MG Metcalfe ◽  
W-J Shieh ◽  
DM Blau ◽  
DC Rollin ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
H1n1 Virus ◽  
Influenza A H1n1 ◽  
Histopathological Studies

Extended abstract of a paper presented at Microscopy and Microanalysis 2010 in Portland, Oregon, USA, August 1 – August 5, 2010.

Sign in / Sign up

Export Citation Format

Share Document